1921
Volume 92, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The Houston West Nile Cohort (HWNC) was founded in 2002 when West Nile virus (WNV) reached Houston, TX. The long-term outcomes following WNV infection are still mostly unknown, though neurological abnormalities up to 1 year postinfection have been documented. We report an observational study of neurological abnormalities at 1–3 and 8–11 years following WNV infection in the HWNC. We conducted standard neurological examinations at two separate time points to assess changes in neurological status over time. The majority of patients (86%, 30/35) with encephalitis had abnormal neurological exam findings at the time of the first assessment compared with uncomplicated fever (27%, 3/11) and meningitis (36%, 5/14) cases. At the time of the second assessment, 57% (4/7) of West Nile fever (WNF), 33% (2/6) of West Nile meningitis (WNM), and 36% (5/14) of West Nile encephalitis (WNE) had developed new neurological complications. The most common abnormalities noted were tandem gait, hearing loss, abnormal reflexes, and muscle weakness. Long-term neurological abnormalities were most commonly found in patients who experienced primary WNV encephalitis. New abnormalities may develop over time regardless of initial clinical infection. Future studies should aim to differentiate neurological consequences due to WNV neuroinvasive infection versus neurological decline related to comorbid conditions.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0616
2015-05-06
2017-09-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/92/5/1006.html?itemId=/content/journals/10.4269/ajtmh.14-0616&mimeType=html&fmt=ahah

References

  1. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, , 2001. Outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 18071814.[Crossref]
  2. Centers for Disease Control and Prevention, 2006. Assessing the capacity for surveillance, prevention, and control of West Nile virus infection—United States, 1999–2004. MMWR 55: 150153.
  3. Lillibridge K, Parsons R, Randle Y, Travassos da Rosa AP, Guzman H, Siirin M, Wuithiranyagool T, Hailey C, Higgs S, Bala AA, Pascua R, Meyer T, Vanlandingham DL, Tesh RB, , 2004. The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. Am J Trop Med Hyg 70: 676681.
  4. Centers for Disease Control and Prevention, 2013. West Nile virus and other arboviral diseases—United States, 2012. MMWR 62: 513517.
  5. Craven RB, Roehrig JT, , 2001. West Nile virus. JAMA 286: 651653.[Crossref]
  6. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, Katz N, Liljebjelke KA, Biggerstaff BJ, Fine AD, Layton MC, Mullin SM, Johnson AJ, Martin DA, Hayes EB, Campbell GL, , 2001. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358: 261264.[Crossref]
  7. Hayes EB, , 2005. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 11: 11741179.[Crossref]
  8. Racsa L, Gander R, Chung W, Southern P, Le J, Beal S, Lee F, Cavuoti D, Reisch J, Alatoom A, , 2014. Clinical features of West Nile virus epidemic in Dallas, Texas, 2012. Diagn Microbiol Infect Dis 78: 132136.[Crossref]
  9. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, Gerber SI, , 2004. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med 141: 360365.[Crossref]
  10. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR, , 2003. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290: 511515.[Crossref]
  11. Granwehr BP, Lillibridge KM, Higgs S, Mason PW, Aronson JF, Campbell GA, Barrett AD, , 2004. West Nile virus: where are we now? Lancet Infect Dis 4: 547556.[Crossref]
  12. Roehrig JT, , 2013. West Nile virus in the United States—a historical perspective. Viruses 10: 30883108.[Crossref]
  13. Sejvar JJ, , 2007. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 44: 16171624.[Crossref]
  14. Klee AL, Maldin B, Edwin B, Poshni I, Motashari F, Fine A, Layton M, Nash D, , 2004. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 10: 14051411.[Crossref]
  15. Tyler KL, , 2004. West Nile virus infection in the United States. Arch Neurol 61: 11901195.[Crossref]
  16. Murray K, Baraniuk S, Resnick M, Arafat R, Kilborn C, Cain K, Shallenberger R, York TL, Martinez D, Hellums JS, Hellums D, Malkoff M, Elgawley N, McNeely W, Khuwaja SA, Tesh RB, , 2006. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 134: 13251332.[Crossref]
  17. Anastasiadou A, Kakoulidis I, Butel D, Kehagia E, Papa A, , 2013. Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis 17: e494e497.[Crossref]
  18. Skoldenberg B, Aurelius E, Hjalmarsson A, Sabri F, Forsgren M, Andersson B, Linde A, Strannegård O, Studahl M, Hagberg L, Rosengren L, , 2006. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol 253: 163170.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0616
Loading
/content/journals/10.4269/ajtmh.14-0616
Loading

Data & Media loading...

Supplementary Data

Supplementary PDF

  • Received : 02 Oct 2014
  • Accepted : 19 Dec 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error